Balanitis Xerotica Obliterans

Thomas RH Meyrick Ridley CM Black MM. Clinical features and therapy of lichen sclerosus et atrophicus affecting males. Clin Exp Dermatol 1987;12:126–8.

Wallace HJ. Lichen sclerosus et atrophicus. Trans Rep St Johns Hosp Dermatol Soc 1971;57:9–30.

Stuhmer A. Balanitis xerotica obliterans (post operationem) and ihre Beziehungen zur “Kraurosis glandis et praeputil Penis”. Arch Dermatol Syphil 1928;156:613–23.

Fruhwald R Zentralbl F Haut U. Penis carcinoma nach Balanitis Xerotica Obliterans. Geschlechtskr 1935;50:98–103.

Grutz O. Beitrage zur klinik der Balanitis Xerotica Obliterans. Dermat Wchnschr 1937;105:1206–9.

Freeman C Laymon CW. Balanitis Xerotica Obliterans. Arch Dermatol Syphil 1941;44:547–51.

Montgomery H Hill W. Lichen Sclerosus et atrophicus. Arch Dermatol Syphil 1940;42:755–60.

Laymon CW Freeman C. Relationship of balanitis xerotica obliterans to lichen sclerosus et atrophicus. Arch Dermatol Syphil 1950;63:310–3.

Garat JM Chechile G Algaba F Santaularia JM. Balanitis xerotica obliterans in children. J Urol 1986;136:436–7.

Mikat DM Ackerman HR Mikat KW. Balanitis xerotica obliterans: Report of a case in an 11 year old and review of the literature. Paediatrics 1973;52:25–8.

Weitzner S. Posthitis xerotica obliterans in a 12 year old boy. Am J Dis Child 1972;123:68–9.

McKay D Fugua F Weinberg A. Balanitis xerotica obliterans in children. J Urol 1975;114:773–5.

Laymon CW. Lichen sclerosus et atrophicus and related disorders. Arch Dermatol Syphil 1951;64:620–7.

Catterall RD Oates JK. Treatment of balanitis xerotica obliterans with hydrocortisone injections. Br J Vener Dis 1962;38:75–9.

Staff WG. Urethral involvement in balanitis xerotica obliterans. Br J Urol 1970;42:234–9.

Bainbridge DR Whitaker RH Shepherd BGF. Balanitis xerotica obliterans and urinary obstruction. Br J Urol 1971;43:487–91.

Potter B. Balanitis xerotica obliterans manifesting on stump of amputated penis. Arch Dermatol 1959;79:473–6.

Khezri AA. Balanitis xerotica obliterans on stump of amputated penis. Br J Urol 1986;58:454–5.

Campus G-U Alia F Bosincu L. Squamous cell carcinoma and lichen schlerosus et atrophicus of the prepuce. Plast Reconstr Surg 1992;89:962–4.

Goolamati SK Barnes EN Irvine WJ Organ specific antibodies in patients with lichen sclerosus. BMJ 1974;iv:78–9.

Harrington CI Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981;104:563–6.

Thomas RH Meyrick Ridley CM Black MM. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol 1983;109:661–4.

Poynter JH Levy J. Balanitis xerotica obliterans: Effective treatment with topical and sub-lesional corticosteroids. Br J Urol 1967;39:420–2.

Campus G-U Ena P Sanderi N. Surgical treatment of balanitis xerotica obliterans. Plast Reconstr Surg 1984;73:652–7.

Parkash S Gajendran V. Meatoplasty for gross urethral stenosis: A technique of repair and a review of 32 cases. Br J Plastic Surgery 1984;37:117–20.

Rosemberg SK Jacobs H. Continuous wave carbon dioxide treatment of balanitis xerotica obliterans. Urology 1982;19:539–41.

Ratz JL. Carbon dioxide laser treatment of balanitis xerotica obliterans. J Am Acad Dermatol 1984;10:925–8.

Rosemberg SK. Carbon dioxide laser treatment of external genital lesions. Urology 1985;25:555–8.